Renhe Pharmacy Co Ltd Total Liabilities

Latest as of March 2026: CN¥823.87 Million CNY ≈ $120.56 Million USD

Renhe Pharmacy Co Ltd total liabilities. Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has total liabilities worth CN¥823.87 Million CNY (≈ $120.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Renhe Pharmacy Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Renhe Pharmacy Co Ltd (1993–2025)

Total liabilities of Renhe Pharmacy Co Ltd from 1993 to 2025. This chart illustrates how Renhe Pharmacy Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Renhe Pharmacy Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Renhe Pharmacy Co Ltd Competitors by Total Liabilities

The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Mercialys SA
PA:MERY
France €1.77 Billion
eXp World Holdings Inc
NASDAQ:EXPI
USA $223.48 Million
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
China CN¥2.76 Billion
Ecopro Co. Ltd
KQ:086520
Korea ₩5.29 Trillion
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
China CN¥802.42 Million
Shanghai QiFan Cable Co Ltd
SHG:605222
China CN¥10.05 Billion
Dorian LPG Ltd
NYSE:LPG
USA $713.63 Million
Neway CNC Equipment Suzhou Co Ltd
SHG:688697
China CN¥3.05 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Renhe Pharmacy Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Renhe Pharmacy Co Ltd asset portfolio.

Liquidity & Leverage Metrics

Renhe Pharmacy Co Ltd Total Liabilities Ratios Explained

Renhe Pharmacy Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 6.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Renhe Pharmacy Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Renhe Pharmacy Co Ltd (1993–2025)

The table below shows the annual total liabilities of Renhe Pharmacy Co Ltd from 1993 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥803.26 Million
≈ $117.54 Million
+18.74%
2024-12-31 CN¥676.48 Million
≈ $98.99 Million
-14.39%
2023-12-31 CN¥790.18 Million
≈ $115.63 Million
-34.69%
2022-12-31 CN¥1.21 Billion
≈ $177.04 Million
+23.33%
2021-12-31 CN¥981.00 Million
≈ $143.55 Million
+41.25%
2020-12-31 CN¥694.54 Million
≈ $101.63 Million
+9.81%
2019-12-31 CN¥632.47 Million
≈ $92.55 Million
-9.86%
2018-12-31 CN¥701.67 Million
≈ $102.68 Million
+0.97%
2017-12-31 CN¥694.95 Million
≈ $101.69 Million
+5.23%
2016-12-31 CN¥660.41 Million
≈ $96.64 Million
+18.91%
2015-12-31 CN¥555.41 Million
≈ $81.27 Million
+27.66%
2014-12-31 CN¥435.06 Million
≈ $63.66 Million
+11.59%
2013-12-31 CN¥389.86 Million
≈ $57.05 Million
+1.85%
2012-12-31 CN¥382.80 Million
≈ $56.02 Million
-16.91%
2011-12-31 CN¥460.68 Million
≈ $67.41 Million
-18.63%
2010-12-31 CN¥566.13 Million
≈ $82.84 Million
+177.90%
2009-12-31 CN¥203.72 Million
≈ $29.81 Million
+54.10%
2008-12-31 CN¥132.20 Million
≈ $19.35 Million
+80.99%
2007-12-31 CN¥73.04 Million
≈ $10.69 Million
-5.16%
2006-12-31 CN¥77.01 Million
≈ $11.27 Million
-81.18%
2005-12-31 CN¥409.12 Million
≈ $59.87 Million
-5.23%
2004-12-31 CN¥431.68 Million
≈ $63.17 Million
-2.16%
2003-12-31 CN¥441.21 Million
≈ $64.56 Million
+4.82%
2002-12-31 CN¥420.93 Million
≈ $61.59 Million
+10.67%
2001-12-31 CN¥380.36 Million
≈ $55.66 Million
+24.18%
2000-12-31 CN¥306.29 Million
≈ $44.82 Million
+42.64%
1999-12-31 CN¥214.72 Million
≈ $31.42 Million
+70.01%
1998-12-31 CN¥126.30 Million
≈ $18.48 Million
+6.35%
1997-12-31 CN¥118.76 Million
≈ $17.38 Million
-6.25%
1996-12-31 CN¥126.67 Million
≈ $18.54 Million
+5.97%
1995-12-31 CN¥119.54 Million
≈ $17.49 Million
-3.67%
1994-12-31 CN¥124.08 Million
≈ $18.16 Million
+6.29%
1993-12-31 CN¥116.74 Million
≈ $17.08 Million
--

About Renhe Pharmacy Co Ltd

SHE:000650 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.05 Billion
CN¥7.18 Billion CNY
Market Cap Rank
#8353 Global
#1874 in China
Share Price
CN¥5.13
Change (1 day)
+0.98%
52-Week Range
CN¥4.98 - CN¥6.38
All Time High
CN¥11.50
About

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more